step 3 semaglutide 🚨 UP Trial: Higher-dose pushes weight loss closer to tirzepatide levels - Switch from Semaglutide to Tirzepatide:

Patients with chronic GI distress often notice meaningful improvement in bloating, regularity, and post-meal discomfort within the first 10 to 14 days

Are sulfur burps a sign that Ozempic is working

Access to treatment plans and medications is not assured

Clinical trial data from the SURMOUNT-1 sub-study showed an average total lean mass loss of 10.9% [4] over the course of the study, and data from the STEP-1 semaglutide study showed a 10% total reduction in skeletal muscle mass [5]

doi: 10.15585/mmwr.mm6650a1 [DOI] [PMC free article] [PubMed] [Google Scholar] 15.Wright DR, Guo J, Hernandez I

Frontiers in Sustainable Food Systems, 3, 17